Get the Stockscreener App
7.675
1.10%
-0.085
After Hours:
7.48
-0.195
-2.54%
Cero Therapeutics Holdings Inc stock is traded at $7.675, with a volume of 26,236.
It is down -1.10% in the last 24 hours and down -16.85% over the past month.
CERo Therapeutics Holdings Inc is an innovative immunotherapy company advancing the development of next-generation engineered T cell therapeutics for the treatment of cancer. Its proprietary approach to T cell engineering, which enables it to integrate certain desirable characteristics of both innate and adaptive immunity into a single therapeutic construct, is designed to engage the body's full immune repertoire to achieve optimized cancer therapy. Its lead molecule is CER-1236, an autologous T-cell product that targets a novel tumor antigen, TIM-4 ligand.
See More
Previous Close:
$7.76
Open:
$7.73
24h Volume:
26,236
Relative Volume:
0.03
Market Cap:
$9.17M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
+1.25%
1M Performance:
-16.85%
6M Performance:
-99.10%
1Y Performance:
-99.88%
1-Day Range:
$7.25
$7.7645
1-Week Range:
$6.81
$8.17
52-Week Range:
$6.71
$17,908.00
Cero Therapeutics Holdings Inc Stock (CERO) Company Profile
Name
Cero Therapeutics Holdings Inc
Sector
Industry
Phone
650-407-2376
Address
201 HASKINS WAY, SOUTH SAN FRANCISCO
Compare CERO with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CERO
Cero Therapeutics Holdings Inc
|
7.675 | 9.27M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
462.13 | 117.32B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
558.87 | 58.89B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
401.80 | 51.14B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
673.80 | 41.02B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
299.01 | 32.59B | 3.81B | -644.79M | -669.77M | -6.24 |
Cero Therapeutics Holdings Inc Stock (CERO) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jun-23-25 | Upgrade | D. Boral Capital | Hold → Buy |
Cero Therapeutics Holdings Inc Stock (CERO) Latest News
Is CERo Therapeutics Holdings Inc. Equity Warrant a growth stock or a value stockFree Stock Trend Scanner For 2025 - jammulinksnews.com
What are the latest earnings results for CERo Therapeutics Holdings Inc.Pre Market Forecasts That Work - jammulinksnews.com
What makes CERo Therapeutics Holdings Inc. Equity Warrant stock price move sharplyEntry Signal Growth Plan For Smart Trading - jammulinksnews.com
Is CERo Therapeutics Holdings Inc. stock overvalued or undervaluedValue Investing Picks For Consistent Profits - jammulinksnews.com
What institutional investors are buying CERo Therapeutics Holdings Inc. stockBest Dividend Updates For Beginners - jammulinksnews.com
Why is CERo Therapeutics Holdings Inc. stock attracting strong analyst attentionMarket Forecast Planner To Watch Now - jammulinksnews.com
CERo doses second patient in Phase 1 AML trial, reports expansion data - Investing.com
CERo Therapeutics Doses Second Acute Myeloid Leukemia Patient with CER-1236 - GlobeNewswire
CERo's Novel CAR-T Therapy Achieves 20.8x Cell Expansion in AML Patient as Second Patient Joins Trial - Stock Titan
Can CERo Therapeutics Holdings Inc. Equity Warrant rally from current levelsAI Screening for Swing Trade Picks Finds Momentum - metal.it
Recovery Signals Appearing in CERo Therapeutics Holdings Inc. ChartsEntry Points For Growing Stocks Identified by Models - metal.it
How CERo Therapeutics Holdings Inc. stock performs during market volatilityWeekly Hot Picks With Buy Confidence Released - metal.it
Published on: 2025-07-29 09:15:16 - metal.it
What are the latest earnings results for CERo Therapeutics Holdings Inc. Equity WarrantTop Growth Review With High Returns - jammulinksnews.com
Heatmap Data Shows High Activity in CERo Therapeutics Holdings Inc. Equity Warrant SectorScalable Portfolio Growth Suggestions Released - metal.it
Is CERo Therapeutics Holdings Inc. a growth stock or a value stockHigh-profit stock alerts - jammulinksnews.com
What is the dividend policy of CERo Therapeutics Holdings Inc. stockConsistent triple-digit returns - jammulinksnews.com
How volatile is CERo Therapeutics Holdings Inc. stock compared to the marketRapid market gains - jammulinksnews.com
Does CERo Therapeutics Holdings Inc. Equity Warrant stock perform well during market downturnsAchieve exceptional returns with expert guidance - jammulinksnews.com
What catalysts could drive CERo Therapeutics Holdings Inc. Equity Warrant stock higher in 2025Outstanding capital returns - jammulinksnews.com
What catalysts could drive CERo Therapeutics Holdings Inc. stock higher in 2025Lightning-fast capital gains - jammulinksnews.com
Should I hold or sell CERo Therapeutics Holdings Inc. stock in 2025Take advantage of unprecedented market momentum - jammulinksnews.com
Why is CERo Therapeutics Holdings Inc. Equity Warrant stock attracting strong analyst attentionGet daily updates on the hottest stocks - jammulinksnews.com
How does CERo Therapeutics Holdings Inc. compare to its industry peersGet expert alerts on market-moving stocks - jammulinksnews.com
How volatile is CERo Therapeutics Holdings Inc. Equity Warrant stock compared to the marketMaximize returns with disciplined investment techniques - jammulinksnews.com
Published on: 2025-07-27 20:32:07 - jammulinksnews.com
New Product Launches: Will They Boost CERo Therapeutics Holdings Inc. Stock in 2025Risk Limited High Gain Trades - metal.it
Published on: 2025-07-27 17:51:39 - jammulinksnews.com
What analysts say about CERo Therapeutics Holdings Inc. Equity Warrant stockFree Popular Stock Recommendations - PrintWeekIndia
Is CERo Therapeutics Holdings Inc. Equity Warrant a good long term investmentBreakthrough profit margins - PrintWeekIndia
CERo Therapeutics Holdings Inc. Stock Analysis and ForecastTremendous financial leverage - Autocar Professional
Will CERo Therapeutics Holdings Inc. stock split in the near futureExplosive trading opportunities - jammulinksnews.com
What drives CERo Therapeutics Holdings Inc. stock priceBreakthrough investment results - PrintWeekIndia
Cero Therapeutics registers up to 12.5M shares for potential sale under equity agreement with Keystone - MSN
CERo Therapeutics Holdings Inc. Equity Warrant Stock Analysis and ForecastExtraordinary performance - PrintWeekIndia
What drives CERo Therapeutics Holdings Inc. Equity Warrant stock priceMarket-leading capital gains - PrintWeekIndia
What analysts say about CERo Therapeutics Holdings Inc. stockRapid return acceleration - PrintWeekIndia
Does CERo Therapeutics Holdings Inc. Equity Warrant stock pay reliable dividendsHigh-octane investment gains - jammulinksnews.com
Is CERo Therapeutics Holdings Inc. Equity Warrant stock overhyped or has real potentialHigh-yield trading alerts - jammulinksnews.com
Cero Therapeutics Holdings Inc Stock (CERO) Financials Data
There is no financial data for Cero Therapeutics Holdings Inc (CERO). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
0.93%
0.15%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):